Why the Challenger (ASX:CGF) share price is one to watch today

The Challenger Ltd (ASX: CGF) share price is one to watch after announcing its latest strategic acquisition before the market open.

The Challenger Ltd (ASX: CGF) share price is one to watch today, after an acquisition update from the Aussie investment group.

woman looking up as if watching asx share price

Image source: Getty Images

Why is the Challenger share price on watch?

Challenger has unveiled its latest acquisition in a pre-trade announcement on Wednesday. The group has entered into an agreement to acquire MyLifeFinance Limited (MLMF) for $35 million.

MLMF is an Australian-based customer savings and loans bank. The bank is currently owned by MyLifeMyMoney Superannuation Fund, also known as Catholic Super.

Challenger hailed the acquisition as "highly strategic" in allowing the group to "significantly expand" its secure retirement income offering.

Challenger will hold an Australian Prudential Regulation Authority (APRA) authorised deposit-taking institution (ADI) licence. That means the group will have access to Australia's $1 trillion term deposit market following the purchase.

The purchase and regulatory capital requirements will be funded by a $100 million distribution from Challenger Life Company Limited in the March 2021 quarter.

The Challenger share price will be one to watch today after closing 2.2% lower at $5.81 per share yesterday.

Management is hoping the MLMF acquisition can also provide other benefits. In particular, the company is looking to expand its customer access through multiple distribution channels.

Challenger Managing Director and CEO, Richard Howes, was bullish on the purchase. Mr Howes said the digital domestic banking capability will broaden Challenger's retirement options.

The acquisition is subject to approval from APRA and the Federal Treasurer and is expected to settle in late March 2021.

What else did Challenger announce?

This morning's announcement also included an update on Challenger's FY2021 earnings. The investment group continues to expect normalised net profit after tax to be within its guidance range of $390 million to $440 million.

One-off transaction and integration costs of $5 million to $8 million (pre-tax) will be incurred in FY2021 and recognised as a significant item.

The Challenger share price is worth watching this morning while the S&P/ASX 200 Index (ASX: XJO) is tipped to open higher.

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

Man in shirt and tie falls face first down stairs.
Record Lows

I think this ASX 200 stock looks like a bargain after hitting an all-time low: Here's why

The ASX shares fell another 8% on Tuesday.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

Man working on a laptop from home.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It could be another tough session for Aussie investors on hump day.

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »